Douglas R Adkins (Douglas Adkins)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Ejection Fraction

Radiation Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Medical oncology (Northwood, London, England)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Shin Saito, Michihisa Kono, Hoang C B Nguyen, Ann Marie Egloff, Cameron M Messier, Patrick H Lizotte, Cloud P Paweletz, Douglas R Adkins, Ravindra Uppaluri
Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Shin Saito, Michihisa Kono, Hoang C B Nguyen, Ann Marie Egloff, Cameron M Messier, Patrick H Lizotte, Cloud P Paweletz, Douglas R Adkins, Ravindra Uppaluri
Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Shin Saito, Michihisa Kono, Hoang C B Nguyen, Ann Marie Egloff, Cameron M Messier, Patrick H Lizotte, Cloud P Paweletz, Douglas R Adkins, Ravindra Uppaluri
Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Shin Saito, Michihisa Kono, Hoang C B Nguyen, Ann Marie Egloff, Cameron M Messier, Patrick H Lizotte, Cloud P Paweletz, Douglas R Adkins, Ravindra Uppaluri
Targeting Dendritic Cell Dysfunction to Circumvent anti-PD1 Resistance in Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Shin Saito, Michihisa Kono, Hoang C B Nguyen, Ann Marie Egloff, Cameron M Messier, Patrick H Lizotte, Cloud P Paweletz, Douglas R Adkins, Ravindra Uppaluri
Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Shin Saito, Michihisa Kono, Hoang C B Nguyen, Ann Marie Egloff, Cameron M Messier, Patrick H Lizotte, Cloud P Paweletz, Douglas R Adkins, Ravindra Uppaluri
Targeting Dendritic Cell Dysfunction to Circumvent anti-PD1 Resistance in Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Miriam T Jacobs, Pamela Wong, Alice Y Zhou, Michelle Becker-Hapak, Nancy D Marin, Lynne Marsala, Mark Foster, Jennifer A Foltz, Celia C Cubitt, Jennifer Tran, David A Russler-Germain, Carly Neal, Samantha Kersting-Schadek, Lily Chang, Timothy Schappe, Patrick Pence, Ethan McClain, Jose P Zevallos, Jason T Rich, Randal C Paniello, Ryan S Jackson, Patrik Pipkorn, Douglas R Adkins, Carl J DeSelm, Melissa M Berrien-Elliott, Sidharth V Puram, Todd A Fehniger
Memory-like differentiation, tumor targeting monoclonal antibodies, and chimeric antigen receptors enhance natural killer cell responses to head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alison E Smith, Stacia Chan, Zhiyong Wang, Asako McCloskey, Quinn Reilly, Jayden Z Wang, Hetika Vora Patel, Keiichi Koshizuka, Harris S Soifer, Linda Kessler, Ashley Dayoub, Victoria M Villaflor, Douglas R Adkins, Justine Yang Bruce, Alan L Ho, Cesar A Perez, Glenn J Hanna, Amaya Gasco Hernandez, Andrew Saunders, Stephen Dale, Jorge Silvio Gutkind, Francis Burrows, Shivani Malik
Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in PIK3CA- and HRAS-dysregulated HNSCC via convergent inhibition of mTOR activity. Cancer research (2023)
Alan L Ho, Nathan R Foster, Alex J Zoroufy, Jordan D Campbell, Francis Worden, Katharine Price, Douglas R Adkins, Daniel W Bowles, Hyunseok Kang, Barbara A Burtness, Eric J Sherman, Roscoe Morton, Luc G T Morris, Zaineb Nadeem, Nora Katabi, Pamela N Munster, Gary K Schwartz
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Peter Oppelt, Jessica Ley, Mackenzie Daly, Jason Rich, Randal Paniello, Ryan S Jackson, Patrik Pipkorn, Jingxia Liu, Hiram Gay, Kevin Palka, Prakash Neupane, Steven Powell, William C Spanos, Mark Gitau, Jose Zevallos, Wade Thorstad, Douglas R Adkins
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial. Medical oncology (Northwood, London, England) 38 (4) (2021)
Tanguy Y Seiwert, Sara E Kochanny, Kevin Wood, Francis P Worden, Douglas R Adkins, James L Wade, Bethany G Sleckman, Daniel Anderson, Ryan J Brisson, Theodore Karrison, Walter M Stadler, Everett E Vokes
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study. Cancer 126 (14) (2020)
Kai C C Johnson, Jessica Ley, Peter Oppelt, Jingxia Lu, Hiram A Gay, Mackenzie Daly, Ryan Jackson, Jason Rich, Patrik Pipkorn, Randal C Paniello, Jose Zevallos, Wade Thorstad, Douglas R Adkins
nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma. Medical oncology (Northwood, London, England) 36 (11) (2019)
Thomas C Westbrook, Ian S Hagemann, Jessica Ley, Kevin Chen, Kevin Palka, Jingxia Liu, Ling Chen, Peter Oppelt, Douglas R Adkins
Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer. Medical oncology (Northwood, London, England) 37 (2) (2019)